Clin2
NCT07452692Likely a fitNot yet recruiting

Skin irritation and allergy test of selegiline patch in healthy adults

Major Depressive Disorder (MDD)

Part of Mental health clinical trials.

This study tests a selegiline skin patch for skin irritation and allergy in healthy people. It helps make sure the patch is safe before it is used for conditions like Parkinson's disease.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
230 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be a healthy adult who does not smoke.
  • Your skin must be free from conditions like eczema, psoriasis, or dermatitis.
  • No history of serious diseases like heart problems, seizures, immune disorders, or recent cancer.
  • Have no significant illness in the last 4 weeks.
  • Your body mass index (BMI) must be between 18.5 and 29.9.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06827431Not yet recruiting· Phase 3
Testing ammoxetine for depression

This trial tests an investigational medication called ammoxetine for people with moderate to severe depression. It aims to see if the drug can reduce depressive symptoms and is for those who haven't had success with certain other antidepressants.

NCT07226661Recruiting· Phase 2
Study of an investigational drug for depression

This trial tests an investigational medication for adults with major depressive disorder who are currently taking an antidepressant but still have symptoms. It aims to see if adding this new drug can improve mood better than a placebo.

Garden Grove, California
NCT07693738Recruiting· Phase 1
SSGJ-716 for healthy adults and people with atopic dermatitis

This trial tests a new medicine, SSGJ-716, in healthy adults and in people with moderate-to-severe atopic dermatitis (a type of eczema). It aims to see if the drug is safe and how the body reacts to it.

Shanghai
NCT07371065Enrolling by invitation· Phase 1
Testing a new drug's safety in healthy adults

This trial tests a new medicine called LY03021 in healthy volunteers to see how safe it is, how the body processes it, and if food changes its effects. It's for people who are generally healthy and not taking other medications.

Shanghai
NCT07404033Recruiting· Phase 1
Testing a lotion for mild to moderate dandruff rash

This trial tests a new lotion for people with mild to moderate seborrheic dermatitis (a common skin condition causing red, scaly patches on the scalp, face, or chest). The study checks safety and how well the lotion works.

Suzhou, Jiangsu
NCT03024671Recruiting
Skin patch testing for how cosmetics affect skin

This trial studies how certain cosmetics affect skin by using a patch test on your back. You might help researchers understand which products are less likely to cause skin reactions.

Bern

Hear when a new Major Depressive Disorder (MDD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.